
    
      The primary efficacy objective of this study is to compare the time to emergence of
      inadequate analgesia of 8 mg Hydromorphone Hydrochloride Extended-Release taken once every 24
      hours versus placebo in the treatment of patients with persistent pain who require an opioid
      medication for control of their pain.
    
  